However, the virus lost the ability to kill cancer cells in a dose-dependent manner after they were preincubated with IFN-β or when the cells secreted their own IFN-β, suggesting that the OV was partially sensitive to the antiviral interferon response. Here, IFNB1 is linked to cancer.